TOM Group Ltd. (TOCOF) Financials Oct 14, 2014, 7:10
TOM Group Ltd. (TOCOF) Financials Oct 14, 2014, 7:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for TOM Group Ltd.
Fiscal year is January-December. All values HKD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.44B 2.46B 2.33B 2.21B 1.93B
Cost of Goods Sold (COGS) incl. D&A 1.76B 1.85B 1.74B 1.58B 1.35B
COGS excluding D&A 1.59B 1.64B 1.52B 1.36B 1.15B
Depreciation & Amortization Expense 161.39M 203.74M 219.41M 224.29M 194.61M
Depreciation 72.75M 64.89M 57.18M 59.31M 79.12M
Amortization of Intangibles 88.64M 138.85M 162.23M 164.98M 115.49M
Gross Income 679.49M 618.54M 582.21M 622.31M 581.42M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 406.66M 435.14M 458.15M 458.18M 453.3M
Research & Development - - - - 0
Other SG&A 406.66M 435.14M 458.15M 458.18M 453.3M
Other Operating Expense 301.51M 285.8M 326.08M 327.79M 333.7M
Unusual Expense (84.18M) 11.51M 267.18M 136.2M 1.73B
EBIT after Unusual Expense 84.18M (11.51M) (267.18M) (136.2M) (1.73B)
Non Operating Income/Expense 370,000 37.66M 25.62M 28.48M 1.54B
Non-Operating Interest Income 22.01M 15.29M 19.75M 16.41M 13.1M
Equity in Affiliates (Pretax) - 0 0 - (20.45M)
Interest Expense 59.55M 60.47M 59.42M 67.55M 66.48M
Gross Interest Expense 59.55M 60.47M 59.42M 67.55M 66.48M
Interest Capitalized 0 0 - 0 0
Pretax Income 18.33M (121.44M) (483.26M) (322.53M) (472.66M)
Income Tax 46.18M 38.93M 27.68M 26.92M 79.55M
Income Tax - Current Domestic - - - 2.43M 32.24M
Income Tax - Current Foreign - - - 39.8M 35.31M
Income Tax - Deferred Domestic - - - (15.31M) 12M
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - 0 0
Equity in Affiliates (31.36M) (16.75M) (14.99M) 5.32M -
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income (59.21M) (177.12M) (525.92M) (344.13M) (552.21M)
Minority Interest Expense 1.3M (9.17M) (27.65M) (6.94M) (2.14M)
Net Income (60.51M) (167.95M) (498.27M) (337.19M) (550.07M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 - 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (60.51M) (167.95M) (498.27M) (337.19M) (550.07M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (60.51M) (167.95M) (498.27M) (337.19M) (550.07M)
EPS (Basic) (0.02) (0.04) (0.13) (0.09) (0.14)
Basic Shares Outstanding 3.89B 3.89B 3.89B 3.89B 3.89B
EPS (Diluted) (0.02) (0.04) (0.13) (0.09) (0.14)
Diluted Shares Outstanding 3.89B 3.89B 3.89B 3.89B 3.89B
EBITDA 132.72M 101.34M 17.38M 60.63M (10.97M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...
Continue Reading
Shenzhen Steps into the Arbitration Spotlight In a move that's bound to tweak some eyebrows in the legal realm, Shenzhen just hosted the 2026 Foreign Direct Investment International Arbitration Moot (FDI Moot) Global Finals. This marks the first time the finals have landed on Chinese soil, and folks, that's a big deal. It’s a hefty nod to China's expanding credibility...
Continue Reading
A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...
Continue Reading
Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...
Continue Reading
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...
Continue Reading
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...
Continue Reading
Why a Trade Fair Needs Lion Dances October 2026 marks a time when talking about a trade fair means diving headfirst into a whirlpool of global exchange and cultural tango we don’t often see in the West. Yeah, I'm looking at you, Canton Fair—a long-runner over in China that's managed to haul in the globe to not just showcase wares, but bring people together in a clash...
Continue Reading
Top 5 Most Recently Viewed Articles
Overview of Horizon Resources Inc.'s New Valuation Horizon Petroleum Ltd. (TSXV: HPL) is thrilled to share the latest updates on significant reserve and resource assessments for its operations in Poland. The company has successfully acquired key assets in the Bielsko-Biala concession affecting the Lachowice gas field. Enjoying the benefits of acquisition through its...
Continue Reading
Revolutionizing Women's Lingerie: Thirdlove's New TempSync™ Collection Thirdlove, a pioneering lifestyle brand dedicated to women's comfort and inclusion, has officially unveiled its innovative TempSync collection. This unique line of temperature-regulating lingerie comprises a T-shirt bra, wireless bra, and hipster, all designed to support women during perimenopause...
Continue Reading
Queclink's Innovative WR310 Series: A New Era of Connectivity Queclink, a global leader in IoT solutions, has proudly launched the WR310 Series, an advanced industrial router designed to meet the burgeoning demands of modern industrial networks. Tailored to provide seamless connectivity, the WR310 Series is set to redefine industrial communications while elevating...
Continue Reading
PRA Celebrates New Steps Towards Healthcare Price Transparency Ensuring patients receive accurate pricing information before they receive care has become a crucial conversation in healthcare. The Patient Rights Advocate (PRA) has taken a momentous stance by applauding recent actions that promote transparency within the healthcare sector. PRA's Support for HHS Initiatives...
Continue Reading
Stifel Financial Corp Shows Significant Q3 Growth Stifel Financial Corp (NYSE: SF) has announced remarkable growth in its third-quarter financial performance. With net revenue reaching $1.23 billion, the company marked a significant 17% rise year-over-year. This impressive figure is notable as it stands as the second-highest quarterly revenue in its history. Additionally,...
Continue Reading